Cullinan Oncology LLC (CGEM) Insider Trading
- $11,332,672.00
- $16,854,232.61
- Feb. 25, 2025
- Jennifer Michaelson
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
April 1, 2022 | Major Shareholder | 276,000 | $10.75 | Buy | $2,967,000.00 | |
Oct. 18, 2021 | Insider | 4,000 | $21.42 | Sell | $85,680.00 | |
Oct. 15, 2021 | CFO | 8,000 | $25.00 | Sell | $200,000.00 | |
Oct. 15, 2021 | Insider | 19,574 | $25.00 | Sell | $489,350.00 | |
Oct. 7, 2021 | Insider | 1,079 | $25.00 | Sell | $26,975.00 | |
Sept. 20, 2021 | Insider | 4,000 | $24.51 | Sell | $98,040.00 | |
Sept. 15, 2021 | Director | 888 | $29.16 | Sell | $25,894.08 | |
Sept. 15, 2021 | Major Shareholder | 6,425 | $29.16 | Sell | $187,353.00 | |
Sept. 13, 2021 | Major Shareholder | 3,595 | $29.10 | Sell | $104,614.50 | |
Sept. 13, 2021 | Director | 497 | $29.10 | Sell | $14,462.70 | |
Sept. 9, 2021 | Director | 1,898 | $29.35 | Sell | $55,706.30 | |
Sept. 9, 2021 | Major Shareholder | 13,727 | $29.35 | Sell | $402,887.45 | |
Sept. 7, 2021 | Major Shareholder | 25,067 | $29.04 | Sell | $727,945.68 | |
Sept. 7, 2021 | Insider | 28,118 | $28.95 | Sell | $814,016.10 | |
Sept. 7, 2021 | Director | 3,465 | $29.04 | Sell | $100,623.60 | |
Sept. 3, 2021 | Major Shareholder | 12,731 | $29.60 | Sell | $376,837.60 | |
Sept. 3, 2021 | Director | 1,760 | $29.60 | Sell | $52,096.00 | |
Sept. 1, 2021 | Major Shareholder | 5,714 | $29.47 | Sell | $168,391.58 | |
Sept. 1, 2021 | Director | 790 | $29.47 | Sell | $23,281.30 | |
Aug. 30, 2021 | Major Shareholder | 31,001 | $29.30 | Sell | $908,329.30 | |
Aug. 30, 2021 | Director | 4,285 | $29.30 | Sell | $125,550.50 | |
Aug. 27, 2021 | Major Shareholder | 13,357 | $29.09 | Sell | $388,555.13 | |
Aug. 27, 2021 | Director | 1,846 | $29.09 | Sell | $53,700.14 | |
Aug. 25, 2021 | Major Shareholder | 1,713 | $29.09 | Sell | $49,831.17 | |
Aug. 25, 2021 | Director | 237 | $29.09 | Sell | $6,894.33 | |
Aug. 23, 2021 | Major Shareholder | 53,359 | $29.11 | Sell | $1,553,280.49 | |
Aug. 23, 2021 | Director | 7,376 | $29.11 | Sell | $214,715.36 | |
Aug. 11, 2021 | Major Shareholder | 2,510 | $29.05 | Sell | $72,915.50 | |
Aug. 11, 2021 | Director | 347 | $29.05 | Sell | $10,080.35 | |
Aug. 9, 2021 | Insider | 21,204 | $26.57 | Sell | $563,390.28 |
Insiders are both buying and selling Cullinan Oncology LLC stock.
The insider traders at Cullinan Oncology LLC are: Jennifer Michaelson, Ansbert Gadicke, Oncology Impact Fund L.P. Ubs, Jeffrey Trigilio, Nadim Ahmed, Jeffrey Alan Jones, Corrine Savill, Leigh Zawel, Vision Scs F2, Bvf Partners L P/Il, Bioscience I 2017 Ltd F2, and Savill Corrine
The most active insider trader at Cullinan Oncology LLC is Jennifer Michaelson with 18 trades.
Oncology Impact Fund L.P. Ubs has sold the most Cullinan Oncology LLC stock with a total value of $5,128,294.40.
Bvf Partners L P/Il has bought the most Cullinan Oncology LLC stock with a total value of $19,497,712.00.
The most recent insider trade for Cullinan Oncology LLC was on Feb. 25, 2025.
The single biggest insider buy for Cullinan Oncology LLC was from Bvf Partners L P/Il with a total value of $8,265,356.00 on June 1, 2022.
The single biggest insider sell for Cullinan Oncology LLC was from Vision Scs F2 with a total value of $2,442,666.00 on May 12, 2022.